XBIT Xbiotech Inc.
-
Xbiotech Reported Earnings
Thursday, August 13, 2026 · 12:00 AM ET
Xbiotech (XBIT) reported a loss of $0.22 per share on revenue of $0.00 million for the . .
XBiotech Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing True Human(TM) monoclonal antibodies for treating diseases. XBiotech Inc. is based in AUSTIN, United States.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($0.22)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—